
Bijan Ahvazi
Examiner (ID: 16926, Phone: (571)270-3449 , Office: P/1763 )
| Most Active Art Unit | 1763 |
| Art Unit(s) | 1763, 4171, 1761, 1796 |
| Total Applications | 1549 |
| Issued Applications | 974 |
| Pending Applications | 113 |
| Abandoned Applications | 482 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6071265
[patent_doc_number] => 20110046116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'SEDATIVE FOR USE DURING EYE SURGERY'
[patent_app_type] => utility
[patent_app_number] => 12/858475
[patent_app_country] => US
[patent_app_date] => 2010-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 642
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20110046116.pdf
[firstpage_image] =>[orig_patent_app_number] => 12858475
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/858475 | SEDATIVE FOR USE DURING EYE SURGERY | Aug 17, 2010 | Abandoned |
Array
(
[id] => 5928873
[patent_doc_number] => 20110038832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'METHOD FOR TREATMENT OF MACULAR DEGENERATION USING (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONE'
[patent_app_type] => utility
[patent_app_number] => 12/857473
[patent_app_country] => US
[patent_app_date] => 2010-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14545
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20110038832.pdf
[firstpage_image] =>[orig_patent_app_number] => 12857473
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/857473 | METHOD FOR TREATMENT OF MACULAR DEGENERATION USING (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONE | Aug 15, 2010 | Abandoned |
Array
(
[id] => 8336458
[patent_doc_number] => 20120203161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-09
[patent_title] => 'DEUTERATED WATER AND RIBOFLAVIN SOLUTION FOR EXTENDING SINGLET OXYGEN LIFETIMES IN TREATMENT OF OCULAR TISSUE AND METHOD OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/390061
[patent_app_country] => US
[patent_app_date] => 2010-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4100
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13390061
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/390061 | DEUTERATED WATER AND RIBOFLAVIN SOLUTION FOR EXTENDING SINGLET OXYGEN LIFETIMES IN TREATMENT OF OCULAR TISSUE AND METHOD OF USE | Aug 11, 2010 | Abandoned |
Array
(
[id] => 5929941
[patent_doc_number] => 20110039900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'ISOTHIOZOLES FOR TREATING CONDITIONS OF THE EYE'
[patent_app_type] => utility
[patent_app_number] => 12/853914
[patent_app_country] => US
[patent_app_date] => 2010-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1196
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20110039900.pdf
[firstpage_image] =>[orig_patent_app_number] => 12853914
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/853914 | ISOTHIOZOLES FOR TREATING CONDITIONS OF THE EYE | Aug 9, 2010 | Abandoned |
Array
(
[id] => 6215305
[patent_doc_number] => 20110137228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'Use of Green Porphyrins to Treat Neovasculature in the Eye'
[patent_app_type] => utility
[patent_app_number] => 12/849581
[patent_app_country] => US
[patent_app_date] => 2010-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6618
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20110137228.pdf
[firstpage_image] =>[orig_patent_app_number] => 12849581
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/849581 | Use of Green Porphyrins to Treat Neovasculature in the Eye | Aug 2, 2010 | Abandoned |
Array
(
[id] => 6196745
[patent_doc_number] => 20110028503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY'
[patent_app_type] => utility
[patent_app_number] => 12/845655
[patent_app_country] => US
[patent_app_date] => 2010-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14376
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20110028503.pdf
[firstpage_image] =>[orig_patent_app_number] => 12845655
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/845655 | COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY | Jul 27, 2010 | Abandoned |
Array
(
[id] => 8196965
[patent_doc_number] => 20120121567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'OPHTHALMIC SOLUTION FOR PROTECTING INTERNAL STRUCTURES OF THE EYEBALL AGAINST UV-A RAYS OR FOR THE TREATMENT OF KERATOCONUS WITH A TRANS-EPITHELIAL CROSS-LINKING TECHNIQUE'
[patent_app_type] => utility
[patent_app_number] => 13/387668
[patent_app_country] => US
[patent_app_date] => 2010-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8338
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20120121567.pdf
[firstpage_image] =>[orig_patent_app_number] => 13387668
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/387668 | Ophthalmic solution for protecting internal structures of the eyeball against UV-A rays or for the treatment of keratoconus with a trans-epithelial cross-linking technique | Jul 22, 2010 | Issued |
Array
(
[id] => 6637631
[patent_doc_number] => 20100312340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'DL-Lactide-Epsilon-Caprolactone Copolymers'
[patent_app_type] => utility
[patent_app_number] => 12/841472
[patent_app_country] => US
[patent_app_date] => 2010-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5355
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20100312340.pdf
[firstpage_image] =>[orig_patent_app_number] => 12841472
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/841472 | DL-lactide-ε-caprolactone copolymers | Jul 21, 2010 | Issued |
Array
(
[id] => 5929846
[patent_doc_number] => 20110039805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'METHOD FOR TREATING MEIBOMIAN GLAND DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/841058
[patent_app_country] => US
[patent_app_date] => 2010-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5365
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20110039805.pdf
[firstpage_image] =>[orig_patent_app_number] => 12841058
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/841058 | METHOD FOR TREATING MEIBOMIAN GLAND DISEASE | Jul 20, 2010 | Abandoned |
Array
(
[id] => 6494471
[patent_doc_number] => 20100286010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'Ophthalmic Compositions with Hyaluronic Acid'
[patent_app_type] => utility
[patent_app_number] => 12/840796
[patent_app_country] => US
[patent_app_date] => 2010-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9585
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20100286010.pdf
[firstpage_image] =>[orig_patent_app_number] => 12840796
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/840796 | Ophthalmic Compositions with Hyaluronic Acid | Jul 20, 2010 | Abandoned |
Array
(
[id] => 6149870
[patent_doc_number] => 20110021465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'SYNERGISTIC COMPOSITION AND METHOD OF RETARDING AND AMELIORATING PHOTO INDUCED RETINAL DAMAGE AND CATARACTS WHILE AMELIORATING DRY EYE SYNDROME'
[patent_app_type] => utility
[patent_app_number] => 12/840396
[patent_app_country] => US
[patent_app_date] => 2010-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14032
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20110021465.pdf
[firstpage_image] =>[orig_patent_app_number] => 12840396
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/840396 | SYNERGISTIC COMPOSITION AND METHOD OF RETARDING AND AMELIORATING PHOTO INDUCED RETINAL DAMAGE AND CATARACTS WHILE AMELIORATING DRY EYE SYNDROME | Jul 20, 2010 | Abandoned |
Array
(
[id] => 6113162
[patent_doc_number] => 20110190250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'EYE DROP WITH DIFLUPREDNATE FOR MACULAR EDEMA TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 13/122467
[patent_app_country] => US
[patent_app_date] => 2010-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5041
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20110190250.pdf
[firstpage_image] =>[orig_patent_app_number] => 13122467
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/122467 | EYE DROP WITH DIFLUPREDNATE FOR MACULAR EDEMA TREATMENT | Jul 13, 2010 | Abandoned |
Array
(
[id] => 10142446
[patent_doc_number] => 09175249
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-03
[patent_title] => 'Ethyleneoxide butyleneoxide block copolymer compositions'
[patent_app_type] => utility
[patent_app_number] => 12/831890
[patent_app_country] => US
[patent_app_date] => 2010-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 5843
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12831890
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/831890 | Ethyleneoxide butyleneoxide block copolymer compositions | Jul 6, 2010 | Issued |
Array
(
[id] => 6353066
[patent_doc_number] => 20100331430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS CONTAINING PROPIONIC PRESERVATIVE COMPONENTS'
[patent_app_type] => utility
[patent_app_number] => 12/824387
[patent_app_country] => US
[patent_app_date] => 2010-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2910
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0331/20100331430.pdf
[firstpage_image] =>[orig_patent_app_number] => 12824387
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/824387 | PHARMACEUTICAL COMPOSITIONS CONTAINING PROPIONIC PRESERVATIVE COMPONENTS | Jun 27, 2010 | Abandoned |
Array
(
[id] => 8173963
[patent_doc_number] => 20120108672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'OPHTHALMIC COMPOSITION AND METHOD FOR PREVENTION OF CLOUDINESS/PRECIPITATION'
[patent_app_type] => utility
[patent_app_number] => 13/380637
[patent_app_country] => US
[patent_app_date] => 2010-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9001
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20120108672.pdf
[firstpage_image] =>[orig_patent_app_number] => 13380637
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/380637 | OPHTHALMIC COMPOSITION AND METHOD FOR PREVENTION OF CLOUDINESS/PRECIPITATION | Jun 22, 2010 | Abandoned |
Array
(
[id] => 9401238
[patent_doc_number] => 08691289
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-08
[patent_title] => 'Methods of treating outer eye disorders using high ORP acid water and compositions thereof'
[patent_app_type] => utility
[patent_app_number] => 12/816731
[patent_app_country] => US
[patent_app_date] => 2010-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12584
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12816731
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/816731 | Methods of treating outer eye disorders using high ORP acid water and compositions thereof | Jun 15, 2010 | Issued |
Array
(
[id] => 6350626
[patent_doc_number] => 20100249134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'Use of Beta-Adrenoceptor Antagonists for the Manufacture of a Medicament for the Treatment of Disorders of the Outer Retina'
[patent_app_type] => utility
[patent_app_number] => 12/796942
[patent_app_country] => US
[patent_app_date] => 2010-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4795
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20100249134.pdf
[firstpage_image] =>[orig_patent_app_number] => 12796942
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/796942 | Use of beta-adrenoceptor antagonists for the manufacture of a medicament of the treatment of disorders of the outer retina | Jun 8, 2010 | Issued |
Array
(
[id] => 6629982
[patent_doc_number] => 20100311688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'OPHTHALMIC FORMULATIONS, METHODS OF MANUFACTURE, AND METHODS OF USING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/794315
[patent_app_country] => US
[patent_app_date] => 2010-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 16737
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311688.pdf
[firstpage_image] =>[orig_patent_app_number] => 12794315
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/794315 | OPHTHALMIC FORMULATIONS, METHODS OF MANUFACTURE, AND METHODS OF USING SAME | Jun 3, 2010 | Abandoned |
Array
(
[id] => 10882585
[patent_doc_number] => 08906965
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-09
[patent_title] => 'Anti-inflammatory quinic acid derivatives for radioprotection/radiomitigation'
[patent_app_type] => utility
[patent_app_number] => 13/320540
[patent_app_country] => US
[patent_app_date] => 2010-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 7341
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13320540
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/320540 | Anti-inflammatory quinic acid derivatives for radioprotection/radiomitigation | May 10, 2010 | Issued |
Array
(
[id] => 6548170
[patent_doc_number] => 20100222369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'TREATMENT FOR DRY EYE CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/774927
[patent_app_country] => US
[patent_app_date] => 2010-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6793
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20100222369.pdf
[firstpage_image] =>[orig_patent_app_number] => 12774927
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/774927 | TREATMENT FOR DRY EYE CONDITIONS | May 5, 2010 | Abandoned |